Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
Background: In the last two decades, the use of erythropoietin for the correction of anemia in hemodialysis patients has been recommended. In Chile, only 10% of hemodialysis patients use erythropoietin, therefore, the correction of iron deficiency must be optimized. Aim: To report the effects of int...
Guardado en:
Autores principales: | Alvo A,Miriam, Elgueta S,Leticia, Aragón V,Henry, Cotera F,Alejandro |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2002
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000800004 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Uso precoz de la eritropoyetina en la prevención de la anemia del prematuro
por: Salvadó G,Antonio, et al.
Publicado: (2000) -
Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis—Mechanistic Insights into Anemia of Inflammation and Its Treatment
por: Lukas Lanser, et al.
Publicado: (2021) -
Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
por: Ishii T, et al.
Publicado: (2021) -
Effect of Lactoferrin Supplementation on Iron Deficiency Anemia in Primary School Children
por: Abeer El-Khawaga, et al.
Publicado: (2019) -
Chronic Kidney Disease Related Anemia- A Narrative Review
por: Martina Hrvačić, et al.
Publicado: (2021)